Aydın MM, Akçalı KC. Liver fibrosis. Turkish J Gastroenterology: Official J Turkish Soc Gastroenterol. 2018;29:14–21.

Article  Google Scholar 

Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis. 2017;37:1–10.

Article  PubMed  Google Scholar 

Pibiri M, Simbula G. Role of the Hippo pathway in liver regeneration and repair: recent advances. Inflamm Regeneration. 2022;42:59.

Article  CAS  Google Scholar 

Yasuda K, Kotaka M, Toyohara T, Sueta SI, Katakai Y, Ageyama N, et al. A nonhuman primate model of liver fibrosis towards cell therapy for liver cirrhosis. Biochem Biophys Res Commun. 2020;526:661–9.

Article  CAS  PubMed  Google Scholar 

Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425–56.

Article  CAS  PubMed  Google Scholar 

Yuan S, Wei C, Liu G, Zhang L, Li J, Li L et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway. 2022;55:e13158.

Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37–55.

Article  CAS  PubMed  Google Scholar 

Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9.

Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019;8.

Gugjoo MB, Amarpal, Fazili MR, Shah RA, Sharma GT. Mesenchymal stem cell: basic research and potential applications in cattle and buffalo. J Cell Physiol. 2019;234:8618–35.

Article  CAS  PubMed  Google Scholar 

Vasanthan J, Gurusamy N, Rajasingh S, Sigamani V, Kirankumar S, Thomas EL et al. Role of human mesenchymal stem cells in regenerative therapy. Cells. 2020;10.

Al-Ghadban S, Bunnell BA. Adipose tissue-derived stem cells: Immunomodulatory effects and therapeutic potential. Physiol (Bethesda Md). 2020;35:125–33.

CAS  Google Scholar 

Bunnell BA. Adipose tissue-derived mesenchymal stem cells. Cells. 2021;10.

Khomich O, Ivanov AV, Bartosch B. Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells. 2019;9.

Wei X, Ma W, Gu H, Liu D, Luo W, Cao S et al. Intra-amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses. 2023;56:e13354.

Yang X, Li Q, Liu W, Zong C, Wei L, Shi Y, et al. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment. Cell Mol Immunol. 2023;20:583–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Huang Y, Zhang N, Qu J, Fang Y, Fu J, et al. Single-cell RNA sequencing reveals reduced intercellular adhesion molecule crosstalk between activated hepatic stellate cells and neutrophils alleviating liver fibrosis in hepatitis B virus transgenic mice post menstrual blood-derived mesenchymal stem cell transplantation. MedComm. 2024;5:e654.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen P, Yuan M, Yao L, Xiong Z, Liu P, Wang Z, et al. Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway. Volume 171. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie; 2024. p. 116133.

Tsuchiya A, Kojima Y, Ikarashi S, Seino S, Watanabe Y, Kawata Y, et al. Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases. Inflamm Regeneration. 2017;37:16.

Article  Google Scholar 

Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Therapy. 2022;7:376.

Article  Google Scholar 

Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu ZN, Niu WX, Zhang N, Ge MX, Bao YY, Ren Y, et al. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation. Acta Pharmacol Sin. 2021;42:1808–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Zeldin S, Shi H, Zhu C, Saito Y, Corey KE, et al. TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis. J Hepatol. 2022;76:910–20.

Article  CAS  PubMed  Google Scholar 

Zhang K, Chang Y, Shi Z, Han X, Han Y, Yao Q, et al. ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation. Sci Rep. 2016;6:30029.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoshida M, Horiguchi H, Kikuchi S, Iyama S, Ikeda H, Goto A, et al. miR-7977 inhibits the Hippo-YAP signaling pathway in bone marrow mesenchymal stromal cells. PLoS ONE. 2019;14:e0213220.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830–41.

Article  CAS  PubMed  Google Scholar 

Baglieri J, Brenner DA, Kisseleva T. The role of Fibrosis and Liver-Associated fibroblasts in the pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci. 2019;20.

Kang SH, Kim MY, Eom YW, Baik SK. Mesenchymal stem cells for the treatment of Liver Disease: Present and perspectives. Gut Liver. 2020;14:306–15.

Article  CAS  PubMed  Google Scholar 

Sun H, Shi C, Ye Z, Yao B, Li C, Wang X, et al. The role of mesenchymal stem cells in liver injury. Cell Biol Int. 2022;46:501–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan M, Yao L, Chen P, Wang Z, Liu P, Xiong Z, et al. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis. Int Immunopharmacol. 2023;125:111134.

Article  CAS  PubMed  Google Scholar 

Liu H, Wang X, Deng H, Huang H, Liu Y, Zhong Z et al. Integrated Transcriptome and Metabolomics to reveal the mechanism of adipose mesenchymal stem cells in treating liver fibrosis. Int J Mol Sci. 2023;24.

Jang YO, Jun BG, Baik SK, Kim MY, Kwon SO. Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis. Clin Mol Hepatol. 2015;21:141–9.

Article  PubMed  PubMed Central  Google Scholar 

Abdelgwad M, Ewaiss M, Sabry D, Khalifa WA, Altaib ZM, Alhelf M. Comparative study on effect of mesenchymal stem cells and endothelial progenitor cells on treatment of experimental CCL4-induced liver fibrosis. Arch Physiol Biochem. 2022;128:1071–80.

Article  CAS  PubMed  Google Scholar 

Liu X, Tan S, Liu H, Jiang J, Wang X, Li L, et al. Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. Hepatology (Baltimore MD). 2023;77:1181–97.

Article  PubMed  Google Scholar 

Liu QW, Ying YM, Zhou JX, Zhang WJ, Liu ZX, Jia BB, et al. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice. Stem Cell Res Ther. 2022;13:224.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Russell JO, Camargo FD. Hippo signalling in the liver: role in development, regeneration and disease. Nat Reviews Gastroenterol Hepatol. 2022;19:297–312.

Article  CAS  Google Scholar 

Li Y, Kang X, Zhou Z, Pan L, Chen H, Liang X, et al. The m(6)a methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis. Mol Therapy: J Am Soc Gene Therapy. 2022;30:3714–28.

Article  CAS  Google Scholar 

Zinatizadeh MR, Miri SR, Zarandi PK, Chalbatani GM, Rapôso C, Mirzaei HR, et al. The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis. Genes Dis. 2021;8:48–60.

Article  CAS  PubMed  Google Scholar 

Fan S, Gao Y, Qu A, Jiang Y, Li H, Xie G, et al. YAP-TEAD mediates PPAR α-induced hepatomegaly and liver regeneration in mice. Hepatology (Baltimore MD). 2022;75:74–88.

Article  CAS  PubMed  Google Scholar 

Du K, Maeso-Díaz R, Oh SH, Wang E, Chen T, Pan C, et al. Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis. Hepatology (Baltimore MD). 2023;77:1998–2015.

Article  PubMed